Copyright: ©Author(s) 2026.
World J Gastrointest Oncol. Jun 15, 2026; 18(6): 118678
Published online Jun 15, 2026. doi: 10.4251/wjgo.v18.i6.118678
Published online Jun 15, 2026. doi: 10.4251/wjgo.v18.i6.118678
Figure 3 Effects of hsa_circ_0003848 on gastric cancer cell function.
A: Real-time quantitative PCR shows higher expression of hsa_circ_0003848 in gastric cancer cells compared to normal GES-1 cells; B: Knockdown efficiency of hsa_circ_0003848 confirmed in GES-1, AGS, and HGC-27 cells using siRNAs; C: Cell counting kit-8 assay shows reduced proliferation in AGS and HGC-27 cells after knockdown; D: Colony formation assay indicates decreased clonogenic ability in AGS and HGC-27 after knockdown; E: Transwell assay shows reduced migration of gastric cancer cells after knockdown; F: Flow cytometry reveals increased apoptosis in AGS and HGC-27 cells after knockdown; G: Cell cycle analysis shows G1 phase arrest in AGS and HGC-27 cells after knockdown. n = 3, bP < 0.01, cP < 0.001. NC: Negative control.
- Citation: Li Z, Zhang B, Hu KF, Cao CL. Hsa_circ_0003848 promotes gastric cancer via miR-144-3p/mesenchymal-epithelial transition factor and serves as a plasma biomarker in Helicobacter pylori infection. World J Gastrointest Oncol 2026; 18(6): 118678
- URL: https://www.wjgnet.com/1948-5204/full/v18/i6/118678.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v18.i6.118678